Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II–III Melanoma Adjuvant TherapyStefan Suciu, Marc Buyse, David Cameron et al.|JNCI Journal of the National Cancer Institute|2017Cited by 93